Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Allergic Asthma”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Post-approval studies (Phase 4)Study completedNCT00639691
What this trial is testing

A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy

Who this might be right for
Asthma
Novartis 48
Not applicableStudy completedNCT03480815
What this trial is testing

Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

Who this might be right for
Severe Allergic Asthma
Chang Gung Memorial Hospital 24
Large-scale testing (Phase 3)Study completedNCT00482248
What this trial is testing

Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

Who this might be right for
Asthma
Novartis 132
Not applicableWithdrawnNCT01002976
What this trial is testing

Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma

Who this might be right for
Severe Allergic Asthma
Carmel Medical Center
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Post-approval studies (Phase 4)Looking for participantsNCT04763447
What this trial is testing

Short Treatment with Omalizumab for Severe Asthma

Who this might be right for
Asthma
Assistance Publique - Hôpitaux de Paris 234
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Not applicableStudy completedNCT02813811
What this trial is testing

Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.

Who this might be right for
Asthma
Portsmouth Hospitals NHS Trust 77
Not applicableWithdrawnNCT01144910
What this trial is testing

The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children

Who this might be right for
Intrinsic AsthmaAllergic AsthmaAllergy+1 more
Johann Wolfgang Goethe University Hospital
Not applicableLooking for participantsNCT05938972
What this trial is testing

Real Life Study of Biologicals in Patients With Severe CRSwNP

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
University Hospital, Ghent 180
Not applicableUnknownNCT06771934
What this trial is testing

Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

Who this might be right for
Allergic Asthma
Qianfoshan Hospital 60
Large-scale testing (Phase 3)Study completedNCT05813470
What this trial is testing

Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma

Who this might be right for
Allergic AsthmaUncontrolled Moderate to Severe
Cinnagen 256
Not applicableLooking for participantsNCT07786870
What this trial is testing

Expression of TSLP Isoforms in Asthma

Who this might be right for
Asthma AtopicAsthma Severe Persistent Uncontrolled
Medical University of Warsaw 70
Early research (Phase 1)Study completedNCT00386178
What this trial is testing

Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma

Who this might be right for
Asthma
University of North Carolina, Chapel Hill 16
Not applicableStudy completedNCT01362621
What this trial is testing

Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

Who this might be right for
Moderate to Severe Allergic Asthma
Novartis Pharmaceuticals 474
Post-approval studies (Phase 4)UnknownNCT04585997
What this trial is testing

Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".

Who this might be right for
AsthmaEosinophilic Asthma
University of Newcastle, Australia 200
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Testing effectiveness (Phase 2)Looking for participantsNCT07342803
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Who this might be right for
Allergic Asthma
Longbio Pharma 200
Testing effectiveness (Phase 2)Study completedNCT03299686
What this trial is testing

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Ended earlyNCT01673672
What this trial is testing

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Who this might be right for
Moderate to Severe Allergic Asthma
Cytos Biotechnology AG 365
Next Page